Moleculin to Present at the Life Sciences Investor Forum
March 24, 2020 07:30 ET
|
Life Sciences Investor Forum; Moleculin Biotech, Inc.
HOUSTON, March 24, 2020 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates...